2378 related articles for article (PubMed ID: 19622512)
1. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.
Liberati A; Altman DG; Tetzlaff J; Mulrow C; Gøtzsche PC; Ioannidis JP; Clarke M; Devereaux PJ; Kleijnen J; Moher D
Ann Intern Med; 2009 Aug; 151(4):W65-94. PubMed ID: 19622512
[TBL] [Abstract][Full Text] [Related]
2. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.
Liberati A; Altman DG; Tetzlaff J; Mulrow C; Gøtzsche PC; Ioannidis JP; Clarke M; Devereaux PJ; Kleijnen J; Moher D
J Clin Epidemiol; 2009 Oct; 62(10):e1-34. PubMed ID: 19631507
[TBL] [Abstract][Full Text] [Related]
3. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.
Liberati A; Altman DG; Tetzlaff J; Mulrow C; Gøtzsche PC; Ioannidis JP; Clarke M; Devereaux PJ; Kleijnen J; Moher D
PLoS Med; 2009 Jul; 6(7):e1000100. PubMed ID: 19621070
[TBL] [Abstract][Full Text] [Related]
4. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration.
Liberati A; Altman DG; Tetzlaff J; Mulrow C; Gøtzsche PC; Ioannidis JP; Clarke M; Devereaux PJ; Kleijnen J; Moher D
BMJ; 2009 Jul; 339():b2700. PubMed ID: 19622552
[TBL] [Abstract][Full Text] [Related]
5. Extending the PRISMA statement to equity-focused systematic reviews (PRISMA-E 2012): explanation and elaboration.
Welch V; Petticrew M; Petkovic J; Moher D; Waters E; White H; Tugwell P;
J Clin Epidemiol; 2016 Feb; 70():68-89. PubMed ID: 26348799
[TBL] [Abstract][Full Text] [Related]
6. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations.
Hutton B; Salanti G; Caldwell DM; Chaimani A; Schmid CH; Cameron C; Ioannidis JP; Straus S; Thorlund K; Jansen JP; Mulrow C; Catalá-López F; Gøtzsche PC; Dickersin K; Boutron I; Altman DG; Moher D
Ann Intern Med; 2015 Jun; 162(11):777-84. PubMed ID: 26030634
[TBL] [Abstract][Full Text] [Related]
7. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
8. Extending the PRISMA statement to equity-focused systematic reviews (PRISMA-E 2012): explanation and elaboration.
Welch V; Petticrew M; Petkovic J; Moher D; Waters E; White H; Tugwell P;
Int J Equity Health; 2015 Oct; 14():92. PubMed ID: 26450828
[TBL] [Abstract][Full Text] [Related]
9. AHRQ series on complex intervention systematic reviews-paper 6: PRISMA-CI extension statement and checklist.
Guise JM; Butler ME; Chang C; Viswanathan M; Pigott T; Tugwell P;
J Clin Epidemiol; 2017 Oct; 90():43-50. PubMed ID: 28720516
[TBL] [Abstract][Full Text] [Related]
10. Preferred reporting items for systematic reviews and meta-analyses in ecology and evolutionary biology: a PRISMA extension.
O'Dea RE; Lagisz M; Jennions MD; Koricheva J; Noble DWA; Parker TH; Gurevitch J; Page MJ; Stewart G; Moher D; Nakagawa S
Biol Rev Camb Philos Soc; 2021 Oct; 96(5):1695-1722. PubMed ID: 33960637
[TBL] [Abstract][Full Text] [Related]
11. Reporting and methodological quality of systematic reviews in the orthopaedic literature.
Gagnier JJ; Kellam PJ
J Bone Joint Surg Am; 2013 Jun; 95(11):e771-7. PubMed ID: 23780547
[TBL] [Abstract][Full Text] [Related]
12. CONSORT 2010 Explanation and Elaboration: Updated guidelines for reporting parallel group randomised trials.
Moher D; Hopewell S; Schulz KF; Montori V; Gøtzsche PC; Devereaux PJ; Elbourne D; Egger M; Altman DG;
J Clin Epidemiol; 2010 Aug; 63(8):e1-37. PubMed ID: 20346624
[TBL] [Abstract][Full Text] [Related]
13. Preferred Reporting Items for Systematic Review and Meta-Analyses of individual participant data: the PRISMA-IPD Statement.
Stewart LA; Clarke M; Rovers M; Riley RD; Simmonds M; Stewart G; Tierney JF;
JAMA; 2015 Apr; 313(16):1657-65. PubMed ID: 25919529
[TBL] [Abstract][Full Text] [Related]
14. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials.
Moher D; Hopewell S; Schulz KF; Montori V; Gøtzsche PC; Devereaux PJ; Elbourne D; Egger M; Altman DG;
Int J Surg; 2012; 10(1):28-55. PubMed ID: 22036893
[TBL] [Abstract][Full Text] [Related]
15. AHRQ series on complex intervention systematic reviews-paper 7: PRISMA-CI elaboration and explanation.
Guise JM; Butler M; Chang C; Viswanathan M; Pigott T; Tugwell P;
J Clin Epidemiol; 2017 Oct; 90():51-58. PubMed ID: 28720513
[TBL] [Abstract][Full Text] [Related]
16. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation.
Shamseer L; Moher D; Clarke M; Ghersi D; Liberati A; Petticrew M; Shekelle P; Stewart LA;
BMJ; 2015 Jan; 350():g7647. PubMed ID: 25555855
[TBL] [Abstract][Full Text] [Related]
17. Preferred reporting items for systematic reviews and meta-analyses (PRISMA) statement and publication bias.
Knobloch K; Yoon U; Vogt PM
J Craniomaxillofac Surg; 2011 Mar; 39(2):91-2. PubMed ID: 21145753
[TBL] [Abstract][Full Text] [Related]
18. Endorsement of PRISMA statement and quality of systematic reviews and meta-analyses published in nursing journals: a cross-sectional study.
Tam WW; Lo KK; Khalechelvam P
BMJ Open; 2017 Feb; 7(2):e013905. PubMed ID: 28174224
[TBL] [Abstract][Full Text] [Related]
19. PRISMA harms checklist: improving harms reporting in systematic reviews.
Zorzela L; Loke YK; Ioannidis JP; Golder S; Santaguida P; Altman DG; Moher D; Vohra S;
BMJ; 2016 Feb; 352():i157. PubMed ID: 26830668
[TBL] [Abstract][Full Text] [Related]
20. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement.
Moher D; Shamseer L; Clarke M; Ghersi D; Liberati A; Petticrew M; Shekelle P; Stewart LA;
Syst Rev; 2015 Jan; 4(1):1. PubMed ID: 25554246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
